Mike Hollan

The Healthcare Businesswomen’s Association will honor the recipient at an event later this year in New York City.

Huestis discusses the ways that quantum simulation and quantum systems can be used in areas such as drug discovery and the creation and protection of intellectual property in the life sciences industry.

Pharm Exec spent the year speaking with some of the most interesting professionals from the life sciences industry.

As companies continued to expand their DE&I efforts, Pharm Exec was there to cover it in 2023.

Pharma marketing teams had to deal with big changes in 2023.

As this exciting technology exploded in 2023, Pharm Exec was there to cover it all.

These stories graced the cover of Pharmaceutical Executive this year

Data will continue to grow in importance in 2024.

Lisa Conte, founder, president, and CEO of Jaguar Health, discusses how a climb up Mount Kilimanjaro would vault her to her true career calling—and spark a decades-long quest to accelerate breakthroughs in plant-based pharmaceuticals and supportive care.

Experts gauge whether the needle is finally moving on the effective structuring of outcomes centered payment agreements—from operational, technology, and acceptance standpoints.

Continuous learning a vital skill for aspiring and established leaders alike.

Farbman discusses the struggles that pharma companies are facing when trying to raise funds and how this is impacting IPOs.

Powley discusses his team’s recent patient journey mapping exercise and the impact it has had on RMMH.

Orne discusses the forces impacting the life sciences market and how companies are reacting.

Heidmann discusses the difficulties of enrolling patients in clinical trials and the ways these issues can be dealt with.

Leuchter discusses FDA’s new pilot program.

Smalley discusses her work with proactive signal detection.

Ho discusses how gamma-delta T cells can improve cancer treatments.

Shields discusses Ferring’s recent $5 million endowment to the American Society of Reproductive Medicine.

McCullar discusses his new role as CEO of RegCell.

There is no cure for having to remember countless logins/passwords.

Solomon discusses new ways that researchers are fighting against bacterial resistance to medications.

Mangal discusses the causes of the shortage and how pharma companies can find solutions.

Raja discusses how the pharma industry can improve its ecological impact.

Schmidt discusses the recent announcement that Medidata and the NCI extended their partnership an additional five years.

Stark discusses pharma’s supply chain and the issues it is facing.

Ito discusses how data-driven AI can be utilized by the pharma industry.

Cunningham discusses the obstacles to raising funds in the current climate.

Morton discusses his transition from working as a urologist to the C-suite.